Hydroxychloroquine’s Role in Pregnancy for Anti-Phospholipid Antibody Patients
Current treatments of anti-phospholipid antibody patients in pregnancy achieve moderate success, prompting the HYPATIA study—a trial investigating hydroxychloroquine’s effect on pregnancy outcomes. Listen to Karen Schreiber, rheumatologist at the Danish Hospital for Rheumatic Diseases, explaining the study in this MEDtalk from SCR23.
Få tilgang
Hvis du er lege, sykepleier eller annen helsepersonell, kan du få tilgang til hele artikkelen ved å opprette en profil på BestPractice Nordic.
- Få tilgang
- Hvis du allerede har en profil: Logg in
